- Saliva test devices, providing non-invasive, rapid diagnostic solutions, are becoming essential tools in healthcare, workplace testing, and at-home health monitoring across North America due to their ease of use, cost-effectiveness, and ability to detect a wide range of conditions from infectious diseases to hormonal imbalances
- The growing demand for saliva-based diagnostics is primarily driven by increasing awareness of early disease detection, advancements in molecular diagnostic technologies, and a shift toward decentralized and remote healthcare solutions
- U.S. dominated the North America saliva test devices market with the largest revenue share of 79% in 2024, fueled by high healthcare spending, strong regulatory support for innovative diagnostics, and growing adoption of home-based testing kits, particularly during and post-COVID-19, with leading companies investing in portable, AI-enabled, and smartphone-integrated solutions
- Canada is expected to be the fastest growing country in the North America saliva test devices market during the forecast period, owing to increased public health initiatives and growing demand for accessible diagnostic tools in rural and underserved communities
- Portable devices segment dominated the North America saliva test devices market with a market share of 70.5% in 2024, driven by its ease of use, mobility, and suitability for point-of-care and remote testing environments
